Product news

Share this article:
The FDA has approved Novo Nordisk's PrandiMet, a combination of the insulin secretagogue repaglinide and metformin for the treatment of type 2 diabetes. 
 
Pasteur, the vaccines division of the Sanofi-Aventis Group, announced that the FDA has licensed Pentacel, a vaccine indicated for active immunization against diphtheria, tetanus, pertussis, poliomyelitis and invasive disease due to Haemophilus influenzae type b. Pentacel vaccine is approved for use in infants and children 6 weeks through 4 years of age (prior to age 5). 
Share this article:
close

Next Article in Business Briefs

Email Newsletters

More in Business Briefs

Novartis apologizes for slow reporting

Novartis is apologizing to Japan after the Ministry of Health, Labor and Welfare said the company had dragged its feet reporting adverse events for two of its cancer drugs.

J&J pulls morcellator from market

The company is calling the move a withdrawal, as opposed to a recall.

Pfizer buys two Baxter vaccines

The meningitis and encephalitis medications earned a combined $300 million last year.